How many acquisitions has Merck made so far?

Merck has completed 33 acquisitions so far, with an average acquisition amount of $2.26B.

Which countries does Merck usually acquire in?

Merck has made acquisitions in 8 countries with the most activity in United States and United Kingdom.

Which is Merck's latest acquisition?

Merck's most recent acquisition is Terns Pharmaceutical, a Developer of therapies for treating liver disease and cancer, acquired in March 2026.

Which sectors does Merck target for acquisitions?

Most of Merck's acquisitions are in Oncology (13) and Immunotherapy (9).

In which year did Merck make the most acquisitions?

Merck was most active in 2019, with 5 acquisitions completed in that year.

List of 33 Acquisitions by Merck (Aug 2026)

Merck has made a total of 33 acquisitions. These were completed across 23 sectors, including Oncology, Immunotherapy, and Infectious Diseases, and spanned 8 countries, most notably United States, United Kingdom, and Israel. Activity peaked in 2019 with 5 acquisitions, and in 2014 and 2020 with 3 acquisitions each. The average number of acquisitions per year for the 2020–2025 period is 1.8, and 1 acquisition has been completed as of the current calendar year. The most recent acquisition is Terns Pharmaceutical in March 2026. Founded in 2017 and based in San Mateo, the firm develops therapies for liver disease and cancer.

Here's the year on year acquisition history of Merck:

Number of Total Acquisitions

Year	# Acquisitions
2026	1
2025	2
2024	2
2023	2
2022	1
2021	2
2020	3
2019	5
2018	2
2017	1
2016	2
2015	1
2014	3
2011	1
2010	2
2007	2
2006	1

View all Acquisitions by Merck

Recent acquisitions by Merck

Merck's most recent acquisition - Terns Pharmaceutical is a Developer of therapies for treating liver disease and cancer, founded in 2017 and located in San Mateo. Merck acquired a 100% stake in it in March 2026 for a price of $*****.

Here is the list of all acquisitions by Merck sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Mar 25, 2026	Terns Pharmaceutical	yuwf	spqa	25	442
Nov 14, 2025	Cidara Therapeutics	ygsn	{qkg	40	452
Jul 09, 2025	Verona Pharma	jpbp	lohg	98	725
Oct 23, 2024	Modifi Bio	bc{i	aakw	11	382
Apr 09, 2024	Abceutics	vkdt	cl{z	67	807